Next report date
Report period
Q1 2024
EPS estimate
−0.99USD
Revenue estimate
—
−3.46USD
−117.26 MUSD
27.72 M
About Biomea Fusion, Inc.
Sector
CEO
Thomas Butler
Headquarters
Redwood City
Website
Employees (FY)
103
Founded
2017
FIGI
BBG00YS4WDC9
Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic disorders, such as diabetes. It offers its lead product candidate, BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. The company was founded by Thomas Butler and Ramses Erdtmann in August 2017 and is headquartered in Redwood City, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BMEA is 10.47 USD — it has decreased by 2.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Biomea Fusion, Inc. stocks are traded under the ticker BMEA.
Biomea Fusion, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
BMEA stock is 4.97% volatile and has beta coefficient of 0.44. Check out the list of the most volatile stocks — is Biomea Fusion, Inc. there?
BMEA earnings for the last quarter are −0.80 USD per share, whereas the estimation was −0.82 USD resulting in a 2.23% surprise. The estimated earnings for the next quarter are −0.85 USD per share. See more details about Biomea Fusion, Inc. earnings.
Yes, you can track Biomea Fusion, Inc. financials in yearly and quarterly reports right on TradingView.
BMEA stock has fallen by 8.24% compared to the previous week, the month change is a 32.58% fall, over the last year Biomea Fusion, Inc. has showed a 65.22% decrease.
BMEA net income for the last quarter is −34.88 M USD, while the quarter before that showed −28.43 M USD of net income which accounts for −22.71% change. Track more Biomea Fusion, Inc. financial stats to get the full picture.
Today Biomea Fusion, Inc. has the market capitalization of 375.76 M, it has decreased by 9.37% over the last week.
No, BMEA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BMEA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biomea Fusion, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 103.00 employees. See our rating of the largest employees — is Biomea Fusion, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Biomea Fusion, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Biomea Fusion, Inc. stock shows the sell signal. See more of Biomea Fusion, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Biomea Fusion, Inc. future price: according to them, BMEA price has a max estimate of 90.00 USD and a min estimate of 14.00 USD. Read a more detailed Biomea Fusion, Inc. forecast: see what analysts think of Biomea Fusion, Inc. and suggest that you do with its stocks.